Subscribe Become an Author Sign Up Log In

White Papers And Industry Reports

Trends, opportunities and the future of drug discovery

A Market Review Of DNA-encoded Libraries Technology In Drug Discovery

   by Irina Bilous, Andrii Buvailo    731
A Market Review Of DNA-encoded Libraries Technology In Drug Discovery

The interest of pharma organizations to DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their own screening programs using DELs, or outsourcing capabilities from specialized DEL providers.

This report provides a bird's view on the DEL market, including a brief summary of DEL technology benefits and limitations, key players, major research deals, and several examples of successful hit discovery programs using DELs. 

Navigating the Challenges of Pharmaceutical Marketing

   by Ben Ramsbottom    2412
Navigating the Challenges of Pharmaceutical Marketing

According to a research report by The Business Research Company, the global pharmaceuticals market was worth $934.8 billion in 2017. This will continue to rise, reaching an incredible $1,170 billion by 2021.

Those who work within the field of pharmaceuticals are well aware of the fragmented and fluctuating nature of the industry. This growing industry is trying to adapt to an ever-changing world in terms of communication, but it is experiencing some roadblocks along the way. We look at some of the most notable challenges facing pharmaceutical marketing today.

2018: AI Is Surging In Drug Discovery Market

   by Andrii Buvailo    14786
2018: AI Is Surging In Drug Discovery Market

Updated: 10.01.2019. Newly added content is marked in the text with "Update" sign.

The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a surge of activity in this area over the last several years. In 2018, things are getting even “hotter” with the increase in the amount of partnerships, investments and other important events, summarized and grouped below into “mini-trends”.

Artificial Intelligence For Drug Discovery Use Cases At Mind the Byte

   by David Vidal    2635
Artificial Intelligence For Drug Discovery Use Cases At Mind the Byte

Artificial intelligence (AI) has become a hot topic in the biopharmaceutical environment and nearly every pharma company in the world has embraced it hoping that it will play a major role in speeding up drug discovery, by reducing R&D costs and avoiding failure in late development stages. According to prospects, AI-driven drug discovery will lead to the development of new and more effective drugs, paving thus the way to personalized medicine.